Edgemond James's Form 4 filing
United Therapeutics Corp (UTHR) · filed Aug 26, 2024
- Accession no.
- 0001415889-24-022228
- Filed
- Aug 26, 2024
- Trade date
- Aug 26, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $2.71M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edgemond JamesCIK 0001636178 | Officer (CFO AND TREASURER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +3,266 | $120.26 | +$392,769.16 | 5,348 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −3,266 | $347.60 | −$1,135,261.6 | 2,082 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +3,400 | $117.76 | +$400,384 | 5,482 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −3,400 | $347.60 | −$1,181,840 | 2,082 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +816 | $120.26 | +$98,132.16 | 2,898 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −557 | $347.60 | −$193,613.2 | 2,341 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +850 | $117.76 | +$100,096 | 3,191 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −576 | $347.60 | −$200,217.6 | 2,615 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −3,266 | $0.00 | $0 | 41,652 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −3,400 | $0.00 | $0 | 154,850 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −816 | $0.00 | $0 | 40,836 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −850 | $0.00 | $0 | 154,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.